Eli Lilly has requested Europe's drug regulator to re-examine its opinion on the company's Alzheimer's drug, the agency said ...

Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.

The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...

The analysis, conducted by Ernst & Young, found the United States imported $203 billion in pharmaceutical products in 2023, ...

Most companies are likely going to feel the impact of President Trump's tariffs. In the video above, BofA Securities senior ...

Prices of medication and other costs could increase by as much as 12.9 percent if the tariffs are put in place ...

Pharmaceutical products have long been spared from trade wars due to the potential harms, but he has repeatedly threatened a ...

Report warns 25% pharma tariff could add $51 billion to US drug costs, impacting prices and global competitiveness.

A report suggests that a proposed tariff could significantly increase medicine costs in America. The analysis estimates a ...

In its Thousand Oaks hometown in California, it was far and away the biggest employer, with 1 in 10 of the town folk working for Amgen. It built sites throughout Europe and Asia, and became even ...

The so-called 'Most Favored Nations' rule would set drug pricing for Medicare in line with the prices paid by other nations, ...